Congenital Disorder of Glycosylation, Type Ia (CDG1A)

Congenital Disorder of Glycosylation, Type Ia(来自ICD-11)
别称:
Pmm2-Congenital Disorder of Glycosylation
Phosphomannomutase 2 Deficiency
Cdg Ia
Cdg1a
Congenital Disorder of Glycosylation Type Ia
Jaeken Syndrome
Carbohydrate-Deficient Glycoprotein Syndrome Type Ia
Congenital Disorder of Glycosylation Type 1a
Congenital Disorder of Glycosylation Ia
Congenital Disorder of Glycosylation 1a
Pmm2 Deficiency
Cdgs1a
Cdg-Ia
Cdgia
Carbohydrate-Deficient Glycoprotein Syndrome, Type Ia, Formerly
Carbohydrate Deficient Glycoprotein Syndrome Type Ia
Glycosylation, Congenital Disorder of, Type Ia
Cdg Syndrome Type Ia
Cdg Syndrome Type 1a
Jaeken's Syndrome
Pmm Deficiency
Pmm2-Cdg
加入收藏
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Congenital Disorder of Glycosylation, Type Ia, also known as pmm2-congenital disorder of glycosylation, is related to congenital disorder of glycosylation, type ic and congenital disorder of glycosylation, type iik, and has symptoms including ataxia, diarrhea and seizures. An important gene associated with Congenital Disorder of Glycosylation, Type Ia is PMM2 (Phosphomannomutase 2), and among its related pathways/superpathways are Metabolism of proteins and Transport to the Golgi and subsequent modification. The drugs Sorbitol and Acetazolamide have been mentioned in the context of this disorder. Affiliated tissues include liver and eye, and related phenotypes are high palate and strabismus
查看原文 参与反馈
相关ID:

基础信息

遗传方式
发病时间
患病率/发病率
相关基因
相关模型
参考文献
MALACARDS
AR
Newborn
1-9/100000
12
70
189

疾病表征

#
分类
表征
HPO概率
Orphanet概率
HPO来源
暂无相关数据

基因 & 突变

#
基因
作用分类
分值
突变数量
暂无相关数据

靶点药物

药物名称
CAS号
研发状态
临床阶段
暂无相关数据

疾病模型

类型
名称
MGI
相关基因
品系来源
文献数量
暂无相关数据

文献报道

标题
PMID
期刊
年代
IF
暂无数据
Wechat
Comparison
Al agent
Tutorials
Back to top